Merck closes $1.35 billion deal for bone marrow disease drug developer

Merck agrees to pay $36 per share in cash for Imago BioSciences


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button